Dr. Paul Szabolcs, MD
Claim this profileChildren's Hospital of Pittsburgh of UPMC
Studies Severe Combined Immunodeficiency
Studies Immunodeficiency
8 reported clinical trials
22 drugs studied
Area of expertise
1Severe Combined Immunodeficiency
HLA positive
CD62L negative
CD45RO positive
2Immunodeficiency
Affiliated Hospitals
Clinical Trials Paul Szabolcs, MD is currently running
Stem Cell Transplant
for Scleroderma
The purpose of this study is to determine whether a regimen of high-dose immunoablative therapy will demonstrate safety that is consistent or improved with other published regimens in SSc patients, while maintaining a treatment effect.
Recruiting1 award Phase 215 criteria
Stem Cell Transplant
for Crohn's Disease
The objective of this study is to evaluate the safety and effectiveness of administering high-dose chemotherapy followed by infusion of autologous CD34-selected peripheral blood stem cells (PBSC) in pediatric and adult patients with severe Crohn's disease.
Recruiting1 award Phase 1 & 2
More about Paul Szabolcs, MD
Clinical Trial Related7 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Paul Szabolcs, MD has experience with
- Alemtuzumab
- Rituximab
- Thiotepa
- CD3/CD19 Negative Allogeneic Hematopoietic Stem Cells
- Unlicensed CBU
- Bilateral Orthotopic Lung Transplant
Breakdown of trials Paul Szabolcs, MD has run
Severe Combined Immunodeficiency
Immunodeficiency
Hyper IgM Syndrome
Chronic Neutropenia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul Szabolcs, MD specialize in?
Paul Szabolcs, MD focuses on Severe Combined Immunodeficiency and Immunodeficiency. In particular, much of their work with Severe Combined Immunodeficiency has involved HLA positive patients, or patients who are CD62L negative.
Is Paul Szabolcs, MD currently recruiting for clinical trials?
Yes, Paul Szabolcs, MD is currently recruiting for 5 clinical trials in Pittsburgh Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Paul Szabolcs, MD has studied deeply?
Yes, Paul Szabolcs, MD has studied treatments such as Alemtuzumab, Rituximab, Thiotepa.
What is the best way to schedule an appointment with Paul Szabolcs, MD?
Apply for one of the trials that Paul Szabolcs, MD is conducting.
What is the office address of Paul Szabolcs, MD?
The office of Paul Szabolcs, MD is located at: Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania 15224 United States. This is the address for their practice at the Children's Hospital of Pittsburgh of UPMC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.